Dr. Brad Herskowitz Participates in SAGE-324 Phase 2 KINETIC Study

Healthcare News / April 19, 2021

Last week Sage Therapeutics, Inc. and Biogen Inc. announced the results from the Phase 2 KINETIC Study evaluating SAGE-324 in the treatment of people with essential tremor. Essential Tremor (ET) …

Dr. Brad Herskowitz Participates in SAGE-324 Phase 2 KINETIC Study Read More »